Verrica Pharmaceuticals Inc (NASDAQ:VRCA)
| 12.85 Delayed Data As of Feb 25 |  -1.06 / -7.62%Today’s Change | 6.84 Today|||52-Week Range 18.67 | -19.13% Year-to-Date |
Latest VRCA News | Press Releases
No recent news for Verrica Pharmaceuticals Inc.
Today’s Trading
| Previous close | 13.91 |
| Today’s open | 14.00 |
| Day’s range | 12.65 - 14.02 |
| Volume | 96,714 |
| Average volume (3 months) | 71,613 |
| Market cap | $376.1M |
Data as of 4:00pm ET, 02/25/2020
Growth & Valuation
| Earnings growth (last year) | -270.77% |
| Earnings growth (this year) | +19.86% |
| Earnings growth (next 5 years) | -78.35% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 4.19 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| REPHRecro Pharma Inc | -0.13 | -0.86% |
| ALBOAlbireo Pharma Inc | -0.20 | -0.82% |
| MNKMallinckrodt Plc | +0.58 | +13.91% |
| NERVMinerva Neuroscience... | -1.10 | -12.24% |
Data as of 6:30pm ET, 02/25/2020
Financials
| Next reporting date | March 5, 2020 |
| EPS forecast (this quarter) | -$0.30 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$20.6M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters West Chester, Pennsylvania |
Forecasts
